The lack of green feed in winter, young pigs susceptible to vitamin A deficiency, severe cases often die. Feeding more carrots can play a preventive role.
Give lactating sows more carrots. The level of vitamin A in the sow's milk is closely related to the supply of carotene in the feed. Always give the lactating sow more carrots. After the sow has eaten carrots, it passes through the wall of the intestine and the wall of the liver. Because of the action of carotenease, the sow can convert carotene into vitamin A and supplement it into the milk. Piglets sucked into breast milk with high vitamin A content can not only prevent the occurrence of vitamin A deficiency, but also be very beneficial to their growth and health.
Feed young pigs directly for supplementation. If the young pigs already eat, they can cook the carrots (better red) and smash them. Add yellow corn porridge and let them feed freely. If the young pig is suffering from vitamin A deficiency, the cooked egg yolk can be crushed, warmed and boiled (better with milk) and allowed to be freely consumed or artificially fed for several days. The effect can be seen.
Disclaimer: Some articles in this website have been transferred from the Internet. If you are involved in third party legal rights, please inform this website. phone
APIs & Intermediates
Intermediates of Cladribine, Carvedilol, Lurasidone, olmesartan,
Risedronate Sodium, Atazanavir, Saxagliptin,
Dabigatran,Dapoxetine,Cefixime,Ceftaroline fosamil and etc.
In the short span of time, we have emerged as most promising
pharmaceutical intermediates manufacturers, chemical intermediates and
bulk drug intermediates suppliers. Our consistent supply, quality
products and dedication towards clients have opened up many
international avenues for our growth.
In addition, the company also can follow the customer's product needs custom synthesis services
MAIN API PRODUCTS USP/BP
|
PRODUCT NAME
|
CAS NUMBER
|
SPEVIFICATION
|
|
Azithromycin
|
117772-70-0
|
BEP
|
|
Cefpirome Sulphate sterile
|
84957-29-9
|
USP JP16
|
|
Ceftriaxone Sodium (Sterile)
|
104376-79-6
|
USP31
|
|
Cefotaxime
|
64485-93-4
|
USP30
|
|
Ciprofloxacin HCL
|
85721-33-1
|
USP/BP
|
|
Gentamicin sulphate
|
1405-41-0
|
BP
|
|
Levofloxacin
|
100986-85-4
|
USP27
|
|
Lincomycin Hydrochloride
|
859-18-7
|
EP6.0
|
|
Moxifloxacin Hydrochloride
|
186826-86-8
|
USP31
|
|
Tigecycline
|
220620-09-7
|
USP
|
|
Linezolid
|
165800-03-3
|
EP
|
|
Dexamethasone
|
50-02-2
|
USP/BP/EP
|
|
Methylprednisolone
|
83-43-2
|
USP/BP/EP
|
|
Dexketoprofen trometamol
|
156604-79-4
|
BP2008
|
|
Ibuprofen
|
15687-27-1
|
BP
|
|
Metamizol
|
68-89-3
|
DAB
|
|
Sulindac
|
38194-50-2
|
USP/BP/EP
|
|
Naproxcinod
|
163133-43-5
|
USP28
|
|
Tripelennamine Hydrochloride
|
154-69-8
|
USP28
|
|
Itraconazole
|
84625-61-6
|
USP/BP
|
|
Cytarabine
|
147-94-4
|
USP31
|
|
Leucovorin Calcium
|
1492-18-8
|
USP32
|
|
Valsartan
|
137862-53-4
|
USP30
|
|
Telmisartan
|
144701-48-4
|
USP31
|
|
Rosuvastatin Calcium
|
147098-20-2
|
USP/BP
|
|
Pitavastatin Calcium
|
147526-32-7
|
USP/BP
|
|
Fluvastatin
|
93957-54-1
|
USP31
|
|
Vinpocetine
|
42971-09-5
|
EP6.0
|
|
Atazanavir
|
198904-31-3
|
BP
|
|
Rosiglitazone
|
122320-73-4
|
USP30
|
|
Esomeprazole Magnesium
|
161973-10-0
|
USP/BP
|
|
Topiramate
|
97240-79-4
|
USP31
|
|
Fexofenadine HCl
|
153439-40-8
|
Inhouse
|
|
Bosentan
|
147536-97-8
|
Inhouse
|
|
D-Cysteine
|
921-01-7
|
Inhouse
|
|
D-Phenylalanine
|
673-06-3
|
Inhouse
|
|
Linagliptin
|
668270-12-0
|
Inhouse
|
|
Rivaroxaban
|
366789-02-8
|
USP
|
|
Saxagliptin
|
361442-04-8
|
USP
|
|
Vildagliptin
|
274901-16-5
|
USP
|
Major Pharmaceutical Intermediates
|
Items Descripation
|
Structure
|
Application
|
MICA ESTER
CAS No: 246035-38-1
Purity: ≥98%
|
|
For Cefixime
|
EHATA
CAS No: 64485-82-1
Purity: ≥98%
|
|
For Ceftazidine
|
2-Chloroadenine
CAS No: 1839-18-5
|
|
For Cladribine, Fludarabine et al
|
Bicyclo(2,2,1)Heptane-2,3-di-exo-carboximide
CAS No: 14805o-29-9
|
|
For Lurasidne
|
(R,R)-1,2-Bis(methanesulfonyloxy methyl)Cyclohexane
CAS No: 186204-35-3
|
|
For Lurasidone
|
3-(Piperazin-1-yl)benzol[d] isothiazole
CAS No: 87691-87-0
|
|
For Lurasidone
|
Trityl olmesartan
CAS No: 144690-92-6
Purity: ≥98%
|
|
For olmesartan
|
3-Acetyl Pyridine
CAS No: 350-03-8
|
|
For Risedronate Sodium
|
3-(AceticAcid)pyridine HCL
CAS No: 6419-36-9
|
|
For Risedronate Sodium
|
Risedronic Acid
CAS No: 105462-24-6
|
|
For Risedronate Sodium
|
3-Hydroxy-1-adamantyl-D-Glycine
CAS No: 709031-29-8
|
|
For Saxagliptin
|
(1s,3s,5s)-3-(aminocarbonyl)-2-azabicyclo(3,1,0) hexane-2-carboxylic acid tert-butyl ester
CAS No: 361440-67-7
|
|
For Saxagliptin
|
(S)-N-Boc-3- hydroxy-adamantylglycine
CAS No: 361442-00-4
|
|
For Saxagliptin
|
2-Azabicyclo[3.1.0] hexane-3-carbonitrile, (1s,3s,5s)-
CAS No: 866083-42-3
|
|
For Saxagliptin
|
Ethyl 3-(pyridin-2-ylamino) propanoate
CAS No: 103041-38-9
|
|
For Dabigatran
|
N-(4-Cyanophenyl) glycine
CAS No: 42288-26-6
|
|
For Dabigatran
|
4-methylamino-3-nitrobenzoic Acid
CAS No: 41263-74-5
|
|
For Dabigatran
|
S-3-Amino-3-phenylpropanoic acid ethyl ester HCL
CAS No: 167834-24-4
|
|
For Dapoxetine
|
(S)-3-Amino-3-Phemylpropan -1-ol
CAS No: 82769-76-4
|
|
For Dapoxetine
|
(S)-3-Dimethylamino-3-Phemylpropanol
CAS No: 82769-75-3
|
|
For Dapoxetine
|
4-{4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butynil}-α,α-dimethyl benzene acetic acid
CAS No: 832088-68-3
|
|
For Fexofenadine HCl
|
Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate
CAS No:154477-54-0
|
|
For Fexofenadine HCl
|
5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
CAS No 461432-22-4
|
|
For Dapagliflozin
|
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether
CAS No :461432-23-5
|
|
For Dapagliflozin
|
Mica Ester,Pharma Intermediates,Ciprofloxacin Hcl Uses,Active Pharmaceutical Ingredients
NINGBO VOICE BIOCHEMIC CO. LTD , https://www.medicine-voice.com